Video | TCTAP 2025

[Clinical Science] Late-Breaking Clinical Trials 2025

April 24, 2025 / 4:30 PM ~ 5:50 PM 📌 Presentation Room 1, Level 1

Moderator(s): Gary S. Mintz, Alan C. Yeung
Panelist(s): Robert Thomas Gerber, John McB. Hodgson, Young Joon Hong, Weon Kim, Jinhyun Lee, Yves R. Louvard, Shigeru Nakamura

• TAVR Indication Expansion Trials: What Are Next?
  Philippe Genereux
• Orbital Atherectomy vs. Conventional Balloon Angioplasty for Severe Calcified Lesion: ECLIPSE Trial
  Ajay J. Kirtane
• Drug-Coated Balloon for Bifurcation Lesion: DCB-BIF Trial
  Shao-Liang Chen
• Panel Discussion I

• Key Findings of the FLAVOUR II Trial
  Jian'an Wang
• Long-Term Final 5-Year Results of FAME-3 Trial
  William F. Fearon
• Stratified Randomization Study to Compare Different Duration of Dual Antiplatelet Therapy After Coronary Stenting in Either High or Low Bleeding Risk Population: HOST-BR Trial
  Hyo-Soo Kim
• Clopidogrel Versus Aspirin Monotherapy in High-Risk Patients After PCI: SMART-CHOICE 3 Trial
  Joo-Yong Hahn
• Panel Discussion II